Titleist Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Titleist Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$735K	Sell	4,661 -355	-7%	-$56K	0.05%	236
2026 Q2	$794K	Sell	5,016 -21	-0.4%	-$2.84K	0.05%	223
2026 Q1	$643K	Sell	5,037 -575	-10%	-$71.8K	0.05%	231
2025 Q4	$684K	Sell	5,612 -81	-1%	-$9.29K	0.06%	188
2025 Q3	$570K	Hold	5,693	–	–	0.05%	191
2025 Q2	$472K	Hold	5,693	–	–	0.05%	210
2025 Q1	$462K	Sell	5,693 -7,656	-57%	-$684K	0.05%	197
2024 Q4	$1.2M	Sell	13,349 -281	-2%	-$27.2K	0.14%	114
2024 Q3	$1.35M	Sell	13,630 -5,903	-30%	-$580K	0.19%	90
2024 Q2	$1.81M	Buy	19,533 +691	+4%	+$62K	0.27%	79
2024 Q1	$1.79M	Buy	18,842 +14,609	+345%	+$1.36M	0.31%	72
2023 Q4	$378K	Buy	+4,233	New	+$314K	0.07%	164

Other funds holding XBI

LHWM

Lake Hills Wealth Management Austin, Texas $218M AUM 31.66% 1-Year Est. Return

AIC

Ayalon Insurance Company Ramat Gan, Israel $1.2B AUM 25.57% 1-Year Est. Return

MWA

MFA Wealth Advisors Pittsburgh, Pennsylvania $589M AUM 19.71% 1-Year Est. Return

MAM

Marotta Asset Management Charlottesville, Virginia $589M AUM 14.57% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

BCG

Breakwater Capital Group Paramus, New Jersey $844M AUM 15.36% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

BONH

Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return

VAG

VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return

WAM

Worth Asset Management Dallas, Texas $343M AUM 29.82% 1-Year Est. Return

Titleist Asset Management's XBI Position: Q3 2026 in Review

Titleist Asset Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 7.1% in Q3 2026, selling an estimated $56K and leaving 4,661 shares worth $735K. The position accounts for 0.05% of the portfolio, ranked #236.

Titleist Asset Management first reported a position in XBI in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.81M in Q2 2024. 39 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

Titleist Asset Management held 4,661 shares of State Street SPDR S&P Biotech ETF worth $735K as of Q3 2026.
Titleist Asset Management sold 355 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $56K.
State Street SPDR S&P Biotech ETF made up 0.05% of Titleist Asset Management's portfolio in Q3 2026, its #236 holding.
Titleist Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 12 quarters since.
Titleist Asset Management's State Street SPDR S&P Biotech ETF position peaked at $1.81M in Q2 2024.
39 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Titleist Asset Management's 13F filing for Q3 2026, filed 8 Oct 2026.